Coronavirus Vaccine News: Moderna Shows 94.5% Success

Share on facebook
Share on twitter
Share on linkedin
Share on telegram
the medical syringe (coronavirus vaccine) is seen with Moderna Therapeutics company logo displayed on a screen in the background-Coronavirus Vaccine News-ss-featured

In the latest coronavirus vaccines news, Moderna Inc reported that its vaccine is 94.5% effective. The report got its date from their ongoing clinical trials. Moderna is the second vaccine in the United States to report excellent success rates. The company shared its results in a call Sunday afternoon. Among those present were members of the Data Safety and Monitoring Board.

 RELATED: 12 Foods to Boost Your Immune System

Coronavirus Vaccine News: Moderna Shows 94.5% Success

Dr. Fauci believes vaccinations can start by mid-December. Therefore, high-risk groups and front liners will take priority. Meanwhile, the rest of the populace will start receiving shots by spring next year.

‘Absolutely Amazing’

Dr. Tal Zacks, Moderna’s chief medical officer, was ecstatic with the results. “It was one of the greatest moments of my life and my career. It is absolutely amazing to be able to develop this vaccine and see the ability to prevent symptomatic disease with such high efficacy,” he said. 

Stéphane Bancel, Moderna CEO, talked to journalists Monday. “Given the importance of severe disease that sometimes leads to hospitalization,” she said. “Those hospitalizations that sometimes lead to ICU, and in the worst-case outcome, death, is a very important impact that we see in our vaccine,” she added.

Easier handling

Moderna said that unlike Pfizer’s vaccine, their version does not need very cold storage. As such, the latter’s vaccine requires storage at -94 degrees Fahrenheit. Consequently, this requirement poses a problem for vaccine storage. This means any solution will need rapid deployment and distribution all over the globe. 

Even better, the vaccine appeared to work the same among different groups. The phase 3 trial included around 30,000 participants all over the United States. This included those over 65, those with high-risk conditions, and people of color. 

Coronavirus Vaccine Progress

A week earlier, Pfizer and BioNTech announced success for their candidate vaccine. Their vaccine achieved 90% effectiveness rates in preventing coronavirus. The two companies said in a joint statement that results exceeded estimates of 60-75%. Patients that took two doses reported 90 percent fewer symptoms. 

Pfizer CEO Albert Bourla, chairman and chief executive, said it was “a great day for science and humanity.” Additionally, he said: “We are reaching this critical milestone in our vaccine development program at a time when the world needs it most with infection rates setting new records, hospitals nearing over-capacity, and economies struggling to reopen.”

Coronavirus Vaccine Trials

In Moderna’s trial, 15,000 study participants received a placebo. Another 15,000 got the Moderna vaccine. Over several months, 90 persons within the placebo group developed Covid-19. 11 developed more severe symptoms. Meanwhile, for the group given the vaccine, only five developed Covid-19. Consequently, none of the five became severely ill. 

Moderna reported that the vaccine did not present any serious side effects. Specifically, a small percentage of participants reported symptoms such as body aches and headaches.

Emergency Use Authorization

Same with Pfizer, Moderna will apply for emergency use authorization. They will do so after completing its safety report later this month. By December, it aims for 20 million doses available for the US. Additionally, Moderna expects 500 million to 1 billion doses available globally next year. 

There won’t be enough vaccines for everyone during the first month. Instead, high priority groups and frontline workers will get the first doses. Dr. Fauci believes everybody will get their vaccines by mid-2021. “I think that everybody else will start to get vaccinated towards the end of April,” he said. “And that will go into May, June, July. It will take a couple of months to do.” 

When Will Coronavirus End?

Such welcome coronavirus vaccine news presents hope to finally solve the coronavirus problem. But, people still need to stay safe by practicing safety. We waited for almost a year for the solution, What’s a few more weeks?

Watch this BBC News reports that Moderna’s covid vaccine shows nearly 95% protection:

Do you foresee the solution to coronavirus this year?

View Results

Loading ... Loading ...

How soon do you see the end to the coronavirus problem? Do you foresee a solution this year? Or will it take some more time? Let us know what you think by sharing your thoughts below.

Was this post helpful?

2 thoughts on “Coronavirus Vaccine News: Moderna Shows 94.5% Success”

  1. I am in a high-risk category. I’m nearly 70 yearsOld. I’ve been in the healthcare profession most of my life I have a masters degree in nursing and even though some side effects may be unknown. The results of the disease are definitely known especially in my age group. I would take the vaccine tomorrow

  2. I think I think everyone in a high-risk category. Should take theThe rest of the vaccine is far less Of a risk than the disease itself

Leave a Comment

Your email address will not be published.